vs

Side-by-side financial comparison of NATIONAL RESEARCH CORP (NRC) and Ponce Financial Group, Inc. (PDLB). Click either name above to swap in a different company.

NATIONAL RESEARCH CORP is the larger business by last-quarter revenue ($35.2M vs $31.4M, roughly 1.1× Ponce Financial Group, Inc.). Ponce Financial Group, Inc. runs the higher net margin — 36.3% vs 5.1%, a 31.2% gap on every dollar of revenue. On growth, Ponce Financial Group, Inc. posted the faster year-over-year revenue change (37.6% vs -4.6%). Ponce Financial Group, Inc. produced more free cash flow last quarter ($54.6M vs $6.1M). Over the past eight quarters, Ponce Financial Group, Inc.'s revenue compounded faster (23.7% CAGR vs -0.2%).

National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska.

Ponce Financial Group, Inc. is a U.S.-based financial holding company operating Ponce Bank as its core subsidiary. It serves multicultural, immigrant and low-to-moderate income communities in the New York metro area, offering retail and commercial banking products including deposits, mortgages, small business financing and personal credit.

NRC vs PDLB — Head-to-Head

Bigger by revenue
NRC
NRC
1.1× larger
NRC
$35.2M
$31.4M
PDLB
Growing faster (revenue YoY)
PDLB
PDLB
+42.3% gap
PDLB
37.6%
-4.6%
NRC
Higher net margin
PDLB
PDLB
31.2% more per $
PDLB
36.3%
5.1%
NRC
More free cash flow
PDLB
PDLB
$48.6M more FCF
PDLB
$54.6M
$6.1M
NRC
Faster 2-yr revenue CAGR
PDLB
PDLB
Annualised
PDLB
23.7%
-0.2%
NRC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NRC
NRC
PDLB
PDLB
Revenue
$35.2M
$31.4M
Net Profit
$1.8M
$10.1M
Gross Margin
Operating Margin
13.3%
43.6%
Net Margin
5.1%
36.3%
Revenue YoY
-4.6%
37.6%
Net Profit YoY
-72.6%
245.6%
EPS (diluted)
$49.58
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NRC
NRC
PDLB
PDLB
Q4 25
$35.2M
$31.4M
Q3 25
$34.6M
$26.7M
Q2 25
$34.0M
$26.5M
Q1 25
$33.6M
$24.6M
Q4 24
$36.9M
$22.8M
Q3 24
$35.8M
$20.2M
Q2 24
$35.0M
$20.2M
Q1 24
$35.3M
$20.5M
Net Profit
NRC
NRC
PDLB
PDLB
Q4 25
$1.8M
$10.1M
Q3 25
$4.1M
$6.5M
Q2 25
$-106.0K
$6.1M
Q1 25
$5.8M
$6.0M
Q4 24
$6.6M
$2.9M
Q3 24
$5.7M
$2.4M
Q2 24
$6.2M
$3.2M
Q1 24
$6.4M
$2.4M
Operating Margin
NRC
NRC
PDLB
PDLB
Q4 25
13.3%
43.6%
Q3 25
22.4%
32.8%
Q2 25
4.7%
30.2%
Q1 25
25.6%
32.5%
Q4 24
26.0%
19.6%
Q3 24
22.3%
15.2%
Q2 24
25.3%
21.8%
Q1 24
24.8%
18.3%
Net Margin
NRC
NRC
PDLB
PDLB
Q4 25
5.1%
36.3%
Q3 25
11.9%
24.3%
Q2 25
-0.3%
23.0%
Q1 25
17.2%
24.2%
Q4 24
17.8%
14.1%
Q3 24
15.9%
12.1%
Q2 24
17.6%
15.8%
Q1 24
18.0%
11.8%
EPS (diluted)
NRC
NRC
PDLB
PDLB
Q4 25
$49.58
$0.43
Q3 25
$0.18
$0.27
Q2 25
$-0.01
$0.25
Q1 25
$0.25
$0.25
Q4 24
$0.27
$0.11
Q3 24
$0.24
$0.10
Q2 24
$0.26
$0.14
Q1 24
$0.27
$0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NRC
NRC
PDLB
PDLB
Cash + ST InvestmentsLiquidity on hand
$4.1M
$126.2M
Total DebtLower is stronger
$596.1M
Stockholders' EquityBook value
$14.0M
$541.5M
Total Assets
$134.9M
$3.2B
Debt / EquityLower = less leverage
1.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NRC
NRC
PDLB
PDLB
Q4 25
$4.1M
$126.2M
Q3 25
$2.2M
$146.6M
Q2 25
$5.3M
$126.6M
Q1 25
$2.5M
$129.9M
Q4 24
$4.2M
$139.8M
Q3 24
$3.5M
$155.8M
Q2 24
$485.0K
$103.2M
Q1 24
$1.7M
$134.7M
Total Debt
NRC
NRC
PDLB
PDLB
Q4 25
$596.1M
Q3 25
$521.1M
Q2 25
$536.1M
Q1 25
$521.1M
Q4 24
$596.1M
Q3 24
$48.7M
$580.4M
Q2 24
$33.3M
$680.4M
Q1 24
$35.2M
$680.4M
Stockholders' Equity
NRC
NRC
PDLB
PDLB
Q4 25
$14.0M
$541.5M
Q3 25
$14.3M
$529.8M
Q2 25
$21.3M
$521.1M
Q1 25
$29.7M
$513.9M
Q4 24
$31.3M
$505.5M
Q3 24
$34.6M
$504.6M
Q2 24
$40.2M
$497.7M
Q1 24
$36.9M
$493.7M
Total Assets
NRC
NRC
PDLB
PDLB
Q4 25
$134.9M
$3.2B
Q3 25
$135.7M
$3.2B
Q2 25
$141.4M
$3.2B
Q1 25
$135.2M
$3.1B
Q4 24
$132.5M
$3.0B
Q3 24
$131.8M
$3.0B
Q2 24
$119.1M
$2.8B
Q1 24
$120.9M
$2.8B
Debt / Equity
NRC
NRC
PDLB
PDLB
Q4 25
1.10×
Q3 25
0.98×
Q2 25
1.03×
Q1 25
1.01×
Q4 24
1.18×
Q3 24
1.41×
1.15×
Q2 24
0.83×
1.37×
Q1 24
0.95×
1.38×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NRC
NRC
PDLB
PDLB
Operating Cash FlowLast quarter
$7.2M
$55.6M
Free Cash FlowOCF − Capex
$6.1M
$54.6M
FCF MarginFCF / Revenue
17.2%
173.9%
Capex IntensityCapex / Revenue
3.2%
3.1%
Cash ConversionOCF / Net Profit
3.99×
5.48×
TTM Free Cash FlowTrailing 4 quarters
$15.7M
$74.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NRC
NRC
PDLB
PDLB
Q4 25
$7.2M
$55.6M
Q3 25
$13.8M
$1.4M
Q2 25
$-1.1M
$6.2M
Q1 25
$6.6M
$13.1M
Q4 24
$6.4M
$7.2M
Q3 24
$9.4M
$-14.6M
Q2 24
$6.8M
$-2.6M
Q1 24
$12.0M
$1.5M
Free Cash Flow
NRC
NRC
PDLB
PDLB
Q4 25
$6.1M
$54.6M
Q3 25
$10.2M
$786.0K
Q2 25
$-4.1M
$5.9M
Q1 25
$3.7M
$12.9M
Q4 24
$1.9M
$4.5M
Q3 24
$7.8M
$-15.0M
Q2 24
$1.5M
$-2.6M
Q1 24
$7.9M
$-315.0K
FCF Margin
NRC
NRC
PDLB
PDLB
Q4 25
17.2%
173.9%
Q3 25
29.4%
2.9%
Q2 25
-12.2%
22.4%
Q1 25
10.9%
52.6%
Q4 24
5.2%
19.7%
Q3 24
21.8%
-74.1%
Q2 24
4.3%
-13.0%
Q1 24
22.4%
-1.5%
Capex Intensity
NRC
NRC
PDLB
PDLB
Q4 25
3.2%
3.1%
Q3 25
10.4%
2.3%
Q2 25
8.8%
1.0%
Q1 25
8.9%
0.6%
Q4 24
12.0%
11.9%
Q3 24
4.5%
2.0%
Q2 24
15.0%
0.3%
Q1 24
11.7%
8.7%
Cash Conversion
NRC
NRC
PDLB
PDLB
Q4 25
3.99×
5.48×
Q3 25
3.34×
0.21×
Q2 25
1.01×
Q1 25
1.15×
2.20×
Q4 24
0.97×
2.46×
Q3 24
1.66×
-5.99×
Q2 24
1.10×
-0.80×
Q1 24
1.89×
0.61×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons